Oncology Corporate Profile
OBI Pharma, Inc., was founded in 2002. Its focus is on the "Unmet Medical Needs" in challenging diseases throughout the world, such as Cancer & Infectious Diseases. OBI strives to improve health and the quality of life through innovative and cost-effective therapeutics. OBI's core competence is its R&D expertise in developing novel cancer and infectious disease therapies. The company has an exciting pipeline of products built on a ground-breaking carbohydrate synthesis discovery platform.